Cellectis S.A. Files 6-K, Reports Board Changes
Ticker: CLLS · Form: 6-K · Filed: Jun 26, 2025 · CIK: 1627281
Sentiment: neutral
Topics: board-changes, disclosure, registration-statement
TL;DR
Cellectis board shake-up incoming via 6-K filing.
AI Summary
Cellectis S.A. filed a Form 6-K on June 26, 2025, reporting changes to its Board of Directors. This filing is incorporated by reference into several of their existing registration statements on Form F-3 and Form S-8.
Why It Matters
Changes in a company's board of directors can signal shifts in strategy, governance, or investor confidence.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of board changes and does not present immediate financial or operational risks.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- June 26, 2025 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form F-3 (document) — Incorporated Registration Statement
- Form S-8 (document) — Incorporated Registration Statement
FAQ
What specific changes were made to Cellectis S.A.'s Board of Directors?
The filing indicates that information regarding board changes is included under the caption '—Board Changes' and in Exhibit 99.2, but the specific details of the changes are not provided in the main text of this Form 6-K.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on June 26, 2025.
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K is to report changes to the registrant's Board of Directors.
Which registration statements does this filing incorporate by reference?
This filing is incorporated by reference into Cellectis S.A.'s registration statements on Form F-3 (No. 333-265826 and 333-284302) and Form S-8 (Nos. 333-204205, 333-214884, 333-222482, 333-227717, 333-258514, 333-267760, 333-273777 and 333-284301).
What is Cellectis S.A.'s principal executive office address?
Cellectis S.A.'s principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 26, 2025 regarding Cellectis S.A. (CLLS).